✦ LIBER ✦

HLA phenotype and secondary failure to oral hypoglycaemic agents

✍ Scribed by A. E. Pontiroli; A. Calderara; F. Capra; B. Fattor; M. T. Illeni; G. Pozza

Book ID: 104698595
Publisher: Springer
Year: 1987
Tongue: English
Weight: 263 KB
Volume: 30
Category: Article
ISSN: 0012-186X
DOI: 10.1007/bf00275753

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A simple clinical approach to discrimina

A simple clinical approach to discriminate between “true” and “pseudo” secondary failure to oral hypoglycaemic agents

✍ L. Scionti; P. Misericordia; A. Santucci; F. Santeusanio; P. Brunetti 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 514 KB

Effects of the combination of insulin an

Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents

✍ S. Stenman; P. -H. Groop; C. Saloranta; K. J. Tötterman; F. Fyhrqvist; L. Groop 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 971 KB

The effects of combined insulin and sulfonylurea therapy on glycaemic control and B-cell function was studied in 15 Type 2 (non-insulin-dependent) diabetic patients who had failed on treatment with oral hypoglycaemic agents. The patients were first treated with insulin alone for four months. Five pa

Comparison of NovoPen 3 and syringes/via

Comparison of NovoPen 3 and syringes/vials in the acceptance of insulin therapy in NIDDM patients with secondary failure to oral hypoglycaemic agents

✍ A Kadiri; A Chraibi; F Marouan; M.R Ababou; N El Guermai; A Wadjinny; A Kerfati; 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 317 KB

Antibodies to Glutamic Acid Decarboxylas

Antibodies to Glutamic Acid Decarboxylase in Japanese Diabetic Patients with Secondary Failure of Oral Hypoglycaemic Therapy

✍ Fukui, M.; Nakano, K.; Shigeta, H.; Yoshimori, K.; Fujii, M.; Kitagawa, Y.; Mori 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

Some patients with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) are positive for antibodies to glutamic acid decarboxylase (anti-GAD), which have been shown to be a useful marker for the diagnosis and prediction of insulin-dependent (Type 1) diabetes mellitus (IDDM). Anti-GAD positive NI

Diagnosis and clinical aspects of second

Diagnosis and clinical aspects of secondary failure of oral antidiabetic agents

✍ Slama, G. 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 242 KB

Effects of a combination of bedtime inte

Effects of a combination of bedtime intermediate-acting insulin and glibenclamide in type 2 (non-insulin-dependent) diabetic patients with secondary failure to respond to oral hypoglycaemic agents

✍ M. Krempf; T. Godeau; S. Ranganathan; P. Blanchard; P. Ritz; B. Charbonnel 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 603 KB

The effect of a subcutaneous injection of an intermediate-acting insulin at bedtime combined with glibenclamide has been evaluated in 16 non-insulin-diabetic patients with secondary failure to respond to oral agents. The patients showed poor metabolic control (HbA1 greater than 11%) after two months